{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:06:08Z","timestamp":1761743168241},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2562,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/ki.2008.545","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T13:38:12Z","timestamp":1227706692000},"page":"S44-S49","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S111","title":["Role of vitamin D receptor activators on cardiovascular risk"],"prefix":"10.1016","volume":"74","author":[{"given":"Jose M.","family":"Valdivielso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Ayus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2008.545_bb0010","series-title":"USRDS 2003 Annual Data Report: Atlas of End-Stage renal disease in the United States, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease","author":"US Renal Data System","year":"2003"},{"key":"10.1038\/ki.2008.545_bb0015","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"10.1038\/ki.2008.545_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/16.suppl_2.7","article-title":"Prevalence of cardiovascular damage in early renal disease","volume":"16","author":"Levin","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.545_bb0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0040","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/17.suppl_8.29","article-title":"C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients","volume":"17","author":"Wanner","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.545_bb0055","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1681\/ASN.V5122024","article-title":"The prognostic importance of left-ventricular geometry in uremic cardiomyopathy","volume":"5","author":"Foley","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0060","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.545_bb0065","first-page":"112","article-title":"Cardiac and circulatory abnormalities in chronic-renal-failure","volume":"1","author":"Ayus","year":"1981","journal-title":"Semin Nephrol"},{"key":"10.1038\/ki.2008.545_bb0070","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2005040392","article-title":"Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study","volume":"16","author":"Ayus","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2796.2005.01544.x","article-title":"Left ventricular function and calcium phosphate plasma levels in uraemic patients","volume":"258","author":"Galetta","year":"2005","journal-title":"J Intern Med"},{"key":"10.1038\/ki.2008.545_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1081\/JDI-100001291","article-title":"Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients","volume":"23","author":"Strozecki","year":"2001","journal-title":"Ren Fail"},{"key":"10.1038\/ki.2008.545_bb0085","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/14.9.2178","article-title":"Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease","volume":"14","author":"Marchais","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0090","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","article-title":"Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure","volume":"66","author":"Neves","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.545_bb0095","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ndt\/gfh205","article-title":"Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging","volume":"19","author":"Hayashi","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0100","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ndt\/11.7.1277","article-title":"Outcome and risk factors for left ventricular disorders in chronic uraemia","volume":"11","author":"Parfrey","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0105","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1681\/ASN.V471486","article-title":"Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients","volume":"4","author":"Harnett","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 4","key":"10.1038\/ki.2008.545_bb0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2165\/00003495-198600314-00023","article-title":"Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertension","volume":"31","author":"Messerli","year":"1986","journal-title":"Drugs"},{"key":"10.1038\/ki.2008.545_bb0115","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00004872-199510000-00003","article-title":"Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment","volume":"13","author":"Muiesan","year":"1995","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2008.545_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.97.1.48","article-title":"Prognostic significance of serial changes in left ventricular mass in essential hypertension","volume":"97","author":"Verdecchia","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.545_bb0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left-ventricular hypertrophy on survival in end-stage renal-disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.545_bb0130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/ndt\/9.8.1136","article-title":"Comparative mortality from cardiovascular disease in patients with chronic renal failure","volume":"9","author":"Brown","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.545_bb0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1081\/JDI-120004094","article-title":"Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients","volume":"24","author":"Nakamura","year":"2002","journal-title":"Ren Fail"},{"key":"10.1038\/ki.2008.545_bb0145","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.V12122768","article-title":"Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis","volume":"12","author":"Zoccali","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0150","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ASN.0000135053.98172.D6","article-title":"Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients","volume":"15","author":"Wang","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0155","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V12122759","article-title":"Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study","volume":"12","author":"London","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0160","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","article-title":"Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression","volume":"65","author":"Zoccali","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.545_bb0165","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/ndt\/gfh288","article-title":"The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey","volume":"19","author":"Paoletti","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ndt\/gfg1083","article-title":"Left ventricular hypertrophy: why does it happen?","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1523-1755.2005.00458.x","article-title":"Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10g\/dl","volume":"68","author":"Ayus","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl 95","key":"10.1038\/ki.2008.545_bb0180","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1523-1755.2005.09506.x","article-title":"The role of vitamin D in left ventricular hypertrophy and cardiac function","volume":"67","author":"Achinger","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2008.545_bb0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-2828(86)80983-X","article-title":"1,25-Dihydroxyvitamin D3 receptors identified in the rat heart","volume":"18","author":"Walters","year":"1986","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/ki.2008.545_bb0190","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1006\/cbir.1996.0081","article-title":"Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart","volume":"20","author":"O\u2019Connell","year":"1996","journal-title":"Cell Biol Int"},{"key":"10.1038\/ki.2008.545_bb0195","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1172\/JCI114097","article-title":"Identification and regulation of 1,25-dihydroxyvitamin-D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin-D3\u2014studies in cultured bovine aortic endothelial-cells and human dermal capillaries","volume":"83","author":"Merke","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.545_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-291X(87)90681-4","article-title":"Receptor for 1,25-Dihydroxyvitamin-D in a vascular smooth-muscle cell-line derived from rat aorta","volume":"146","author":"Kawashima","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2008.545_bb0205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000183125","article-title":"Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone","volume":"36","author":"McGonigle","year":"1984","journal-title":"Nephron"},{"key":"10.1038\/ki.2008.545_bb0210","first-page":"579","article-title":"The influence of 1 alpha-hydroxycholecalciferol on left ventricular function in end-stage renal failure","volume":"18","author":"McGonigle","year":"1981","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.1038\/ki.2008.545_bb0215","first-page":"E675","article-title":"Involvement of vitamin D3 with cardiovascular function. II. direct and indirect effects","volume":"253","author":"Weishaar","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2008.545_bb0220","first-page":"E134","article-title":"Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties","volume":"258","author":"Weishaar","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2008.545_bb0225","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI118582","article-title":"1,25 (OH)(2) vitamin D-3 and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes","volume":"97","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.545_bb0230","first-page":"H1751","article-title":"1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy","volume":"272","author":"O\u2019Connell","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2008.545_bb0235","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000013384","article-title":"Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis","volume":"18","author":"Lemmila","year":"1998","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2008.545_bb0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","article-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","volume":"33","author":"Park","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0245","doi-asserted-by":"crossref","first-page":"c21","DOI":"10.1159\/000088295","article-title":"Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis","volume":"102","author":"Kim","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2008.545_bb0250","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin\u2013angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2008.545_bb0255","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","article-title":"Activated Vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals","volume":"104","author":"Bodyak","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2008.545_bb0260","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/FJC.0b013e3181761906","article-title":"1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure- prone (cp\/+) rats independent of changes in serum leptin","volume":"51","author":"Mancuso","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/ki.2008.545_bb0265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-2828(86)80937-3","article-title":"Deficiency in dietary vitamin D, not calcium, alters noradrenergic responsiveness in rat atria in vitro","volume":"18","author":"Baksi","year":"1986","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/ki.2008.545_bb0270","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D-3 is a negative endocrine regulator of the renin\u2013angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.545_bb0275","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/S0021-9258(18)61537-6","article-title":"1,25-Dihydroxyvitamin D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells","volume":"262","author":"Walters","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2008.545_bb0280","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/endo.136.2.7835280","article-title":"Inhibition of cardiac myocyte maturation by 1,25-dihydroxyvitamin D3","volume":"136","author":"O\u2019Connell","year":"1995","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2008.545_bb0285","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1016\/S0021-9258(17)37635-4","article-title":"Negative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3","volume":"269","author":"Li","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2008.545_bb0290","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/ndt\/gfl098","article-title":"Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy","volume":"21","author":"Briese","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.545_bb0295","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V105980","article-title":"Differential effects of 1,25-dihydroxy-vitamin D-3 and 19-nor-1,25-dihydroxy-vitamin D-2 on calcium and phosphorus resorption in bone","volume":"10","author":"Finch","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0300","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1053\/ajkd.2001.28114","article-title":"Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism","volume":"38","author":"Llach","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0305","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1053\/ajkd.1998.v32.pm9808145","article-title":"Therapy of secondary hyperparathyroidism with 19-nor-1 alpha,25-dihydroxyvitamin D-2","volume":"32","author":"Martin","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0310","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","article-title":"A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content","volume":"30","author":"Takahashi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0315","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0320","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol","volume":"38","author":"Sprague","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0325","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0330","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1038\/ki.2008.545_bb0335","first-page":"117","article-title":"[Differential effect of vitamin D analogues on the proliferation of vascular smooth muscle cells]","volume":"23","author":"Cardus","year":"2003","journal-title":"Nefrologia"},{"key":"10.1038\/ki.2008.545_bb0340","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.070305","article-title":"Differential effects of vitamin D analogues on vascular calcification","volume":"22","author":"Cardus","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2008.545_bb0345","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08037050152669710","article-title":"Pulse pressure: an independent predictor of coronary and stroke mortality in elderly females from the general population","volume":"10","author":"Mazza","year":"2001","journal-title":"Blood Press"},{"key":"10.1038\/ki.2008.545_bb0350","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/S0895-7061(99)80045-4","article-title":"Pulse pressure: a predictor of cardiovascular mortality among young normotensive subjects","volume":"12","author":"Fang","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1038\/ki.2008.545_bb0355","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators on vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.545_bb0360","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/jpet.106.101261","article-title":"Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification","volume":"318","author":"Wu-Wong","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/ki.2008.545_bb0365","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0002-9629(15)40549-X","article-title":"The role of phosphorus in the of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure","volume":"317","author":"Slatopolsky","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1038\/ki.2008.545_bb0370","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"10.1038\/ki.2008.545_bb0375","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2008.545_bb0380","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.545_bb0385","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.2004090765","article-title":"High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination","volume":"16","author":"Ohtake","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0390","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0395","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/hh2401.101070","article-title":"Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers","volume":"89","author":"Steitz","year":"2001","journal-title":"Circ Res"},{"key":"10.1038\/ki.2008.545_bb0400","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","article-title":"Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells","volume":"62","author":"Chen","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.545_bb0405","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.RES.84.2.166","article-title":"Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin","volume":"84","author":"Wada","year":"1999","journal-title":"Circ Res"},{"key":"10.1038\/ki.2008.545_bb0410","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0415","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.545_bb0420","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1681\/ASN.2006080923","article-title":"Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?","volume":"17","author":"Achinger","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.545_bb0425","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0272-6386(01)80074-3","article-title":"Continuous quality improvement: DOQI becomes K\/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative","volume":"37","author":"Eknoyan","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.545_bb0430","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5414\/CNP66433","article-title":"Effects of an increase in time vs frequency on cardiovascular parameters in chronic hemodialysis patients","volume":"66","author":"Weinreich","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2008.545_bb0435","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","article-title":"Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial","volume":"298","author":"Culleton","year":"2007","journal-title":"JAMA"},{"key":"10.1038\/ki.2008.545_bb0440","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.ki.5002044","article-title":"Phosphorus balance and mineral metabolism with 3h daily hemodialysis","volume":"71","author":"Ayus","year":"2007","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815532444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815532444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T07:09:43Z","timestamp":1632380983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815532444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":87,"alternative-id":["S0085253815532444"],"URL":"https:\/\/doi.org\/10.1038\/ki.2008.545","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}